#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Chronic hepatitis B Liver transplant rejection Immunodeficiency congenital Langerhans' cell histiocytosis Autoimmune hepatitis Hypereosinophilic syndrome Rectal cancer Immune-mediated enterocolitis Hypomagnesaemia Gastrointestinal stromal tumour Neurodermatitis Vulval cancer recurrent Immunodeficiency Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Life with Disease Hepatoblastoma Haemolytic uraemic syndrome – Diagnostics Thrombotic thrombocytopenic purpura Noonan syndrome – Treatment Pemphigoid – Diagnostics Mucous membrane pemphigoid – Treatment Cerebral arteriovenous malformation haemorrhagic – Treatment Hereditary hypophosphataemic rickets – Trials in Disease Shprintzen-Goldberg syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ucp2 Cx-037231 Degarelix Acetate SAR444336 LY3841136 SODIUM GSKVX000000070250 Simoctocog Alfa CLESROVIMAB INF904 Mesenchymal Cells ALN-961583 Raludotatug Deruxtecan Hyoscine PROMESTRIENE Isoniazid Golimumab Pyridoxine Fentanyl Citrate Filgrastim Dirocaftor More therapies…

    Learn about Your Condition

    Red blood cell abnormality Atrial septal defect Biliary tract operation Arteriosclerosis Post procedural oedema Gastrectomy Haemorrhagic stroke Neonatal anoxia Angiosarcoma Diabetic autonomic neuropathy Foot deformity Genital herpes Infant sedation Acute coronary syndrome Staphylococcal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin

    Recruiting

    2 1 1
    Investigated Drugs:
    • IMMUNOSTEM
    Italy

  • Study of Cerebrolysin to improve arm function in patients recovering from ischemic stroke

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Cerebrolysin Concentrate
    • Sodium Chloride
    Romania

  • Study of Zolbetuximab combined with Paclitaxel and Ramucirumab for patients with previously treated CLDN18.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Zolbetuximab
    Belgium

  • Evaluating Hyperbaric Oxygen Treatment in Addition to Standard Care for Patients with Necrotizing Soft-Tissue Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oxygen
    Belgium Denmark Finland Norway Sweden

  • Study of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludarabine Phosphate Ph. Eur.
    • Treosulfan
    • Venetoclax
    Germany

  • Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol
    • Dupilumab
    Austria Denmark France Germany Hungary Italy +4
Previous Page
1 … 147 148 149 150 151 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!